Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride use in young people may increase risk of suicidal thoughts and mental health issues.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Habit reversal training effectively treats hair-pulling disorder in both adults and children.

Midazolam impairs learning and memory by increasing neurosteroids through specific receptor activation.

Phototherapy is effective and well-tolerated for treating childhood psoriasis and pityriasis lichenoides chronica.

Finasteride improved reflexes and motor activity in rats with liver-related brain issues.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

New treatments for PCOS using smart drug delivery, metabolic changes, and AI show promise but need more research.

Bupropion causes more hair loss than other antidepressants, with paroxetine causing the least.

Light therapy may improve eye conditions by stimulating cell activity and increasing oxygen availability.

The conclusion is that a team of skin doctors and psychiatrists is needed to better treat patients with mind-skin disorders.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Combination therapies might work better for some vitiligo patients, but results vary.

Pediatricians can effectively treat most acne cases with the right knowledge and patient involvement.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Melatonin may help treat PCOS symptoms in rats.

Tianmeng oral liquid may help with insomnia, anxiety, and depression.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

Children with trichotillomania often pull hair from their scalp and may have other mental health issues.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.